A B S T R A C T The normal metabolic turnover of plasma kininogens was studied by measuring the disappearance of intravenously administered radiolabeled human and monkey plasma kininogens from the circulation of healthy adult rhesus monkeys. Curves obtained by plotting log radioactivity against time could be expressed as double exponential equations, with the first term representing diffusion, and the second, catabolism. No significant difference between the turnovers of human and monkey kininogens was observed. The difference between the t112 of high molecular weight kininogen (25.95±1.60 h) (mean +SEM) and that of low molecular weight kininogen (18.94±1.93 h) was only marginally significant (P < 0.05). In contrast, a highly significant (P < 0.001) difference in their mean catabolic rates (1.12±0.08 d-l for high molecular weight kininogen vs. 2.07±0.09 d-l for low molecular weight kininogen) was observed. These differences between the two kininogens were attributed to differences in their distribution between the intra-and extravascular pools. Studies of kininogen turnover will be useful in elucidating the in vivo func-
INTRODUCTION
The kinins are a group of polypeptides known primarily for their potent vasodilatory actions in addition to their ability to cause increased capillary permeability (1, 2) . They are generated in plasma through enzymatic cleavage of a precursor protein, kininogen, by plasma kallikrein (3) . Plasma kallikrein is formed from its precursor, prekallikrein, and this conversion is dependent upon the presence of activated Hageman factor (blood coagulation Factor XII) (4) . Because of their profound physiologic actions, the kinins have been implicated in the pathophysiology of a wide variety of clinical disorders which include carcinoid syndrome (5) , hereditary angioedema (6) , dumping syndrome (7), Gram-negative septicemia (8) , and disseminated intravascular coagulation (9) . Documentation of the involvement of the kinin system in these various disorders, however, has been limited to the observation of elevated plasma kinin and kallikrein activities, and the depletion of their precursor proteins, kininogen and prekallikrein. Such observations only imply kinin system activation. No data regarding the specific kinetics of kinin system proteins in these disorders are available.
Recent advances in the isolation and purification of plasma kininogens (10) have enabled us to examine the normal turnover of these proteins. By intravenous injection into rhesus monkeys of radiolabeled, purified human and monkey kininogens, and subsequent measurement of their disappearance, we have endeavored to characterize the kinetics of these proteins in plasma. We hope to use this information to study kininogen turnover in various disease states to clarify the role of the kinin system, if any, in their pathogenesis.
METHODS
Isolation of kininogens. Kininogens were purified with the affinity chromatographic methods of Pierce and Guimaraes (10) as outlined in Fig. 1 . 2 liters of either human or monkey blood were drawn into plastic receptacles which contained 1 part 3.8% sodium citrate, 0.1% hexadimethrine bromide (Aldrich Chemical Co., Inc., Milwaukee, Wis.), and 0.01 M benzamidine chloride (Calbiochem, San Diego, Calif.), to 9 parts whole blood. The samples were centrifuged at 25°C for 10 min at 2,000 g, and the plasma supernate (520 ml) was chromatographed on a 2.6-x 40.0-cm column of L-lysine coupled to Sepharose 4B (Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N. J.) which was prepared as described by Deutsch and Mertz (11) . The plasminogen-free plasma (580 ml) thus obtained was stirred into 4 liters of a solution that contained 50 g dry weight of DEAE-cellulose Animal studies. Adult male rhesus monki mulatta), which weighed 3.5-6.0 kg, were before injection of radiolabeled kininogen, e was administered 1 ml of a saturated solution for the duration of the study, all fluid intake to a solution that contained 0.02% Nal. Durir injection of kininogen, and for each subse sampling, the monkeys were anesthetized wi HCl (10 mg/kg, i.m. RESULTS The disappearance curves of radiolabeled human kininogens from plasma of rhesus monkeys could be expressed as double exponential equations (Fig. 3) . Like fibrinogen (22, 23) , kininogen had a high metabolic rate, and first-order diffusion and catabolic characteristics. HMW Table I . Plasma tl12 of HMW kininogens was 25.95±+1.60 h (mean± SEM), while that of LMW kininogen was 18.94±1.93 h; a difference that was only marginally significant (P < 0.05). On the other hand, a highly significant difference (P < 0.001) existed between their Fc. Because plasma t1/2 is a measure of catabolism of only the kininogen in the intravascular pool, and Fc is dependent upon both intra-and extravascular pools of kininogen, it follows that the observed differences between HMW and LMW kininogens result from differences either in intravascularextravascular flux or in pool size. A significant difference in ev/iv existed, with HMW kininogen being partitioned primarily into the intravascular pool, and LMW kininogen being more equally distributed between the two pools. Although Fi, e of HMW kininogen was slower than that of LMW kininogen, the difference was not significant. No coefficients for multiple regressions. Correlation (r) values for the double exponentials were in excess of 0.9900 for all of the studies (Table III) . Equally notable was the absence of any improvement in fit of the curves to triple exponential equations. Measurement of turnover by following the disappearance of plasma radioactivity was compared with the disappearance of whole blood radioactivity and antibody-precipitated kininogen antigen radioactivity. Less than 10% of total radioactivity remained in the supernate after immunoprecipitation of kininogen. Turnover curves obtained by measuring whole blood and immunoprecipitated kininogen radioactivity were not significantly different from plasma studies, nor were they significantly different from each other. This was true for all forms of kininogen tested.
Because so-called HMW kininogen and LMW kininogen are each mixtures of kininogens of various molecular weights, their turnover curves were compared with those of the pure 80,000 and 225,000 molecular weight proteins, B3a and B4y. As shown in Fig. 4 , the turnover curves for B3a and B4y were not significantly different from their counterparts of lesser purity, which indicates that the heterogeneous composition of our HMW and LMW kininogen preparations did not alter the basic kinetic characteristics of their respective major components. The data discussed have referred exclusively to turnover of human kininogens. Because of the phylogenetic similarity between monkeys and humans, and because of the identity in the measured biochemical and antigenic characteristics of their kininogens, we assumed that human kininogens would have similar turnover kinetics compared with monkey kininogens when studied in rhesus monkeys. The accuracy of this assumption was tested and our results are depicted in Fig. 5 . The disappearance curves for radiolabeled monkey HMW and LMW kininogens fell within the 95% confidence limits of the curves for their corresponding human kininogens.
While there was no difference in their plasma t1/2, Fc of monkey LMW kininogen, 1.10+0.14 d-l was significantly lower (P < 0.001) than that of human LMW kininogen, 2.07+0.09 d-1. There were no significant differences in Fi, e or in Fe, i to explain the lower catabolic rate, but the ev/iv for monkey LMW kininogen, 0.64+0.03, was significantly smaller (P < 0.01) than that for human LMW kininogen, 1.052 +0.068.
DISCUSSION
We have characterized the normal turnover of kininogens by measuring their disappearance from the plasma of rhesus monkeys after bolus injection. The relatively rapid metabolic rate observed for kininogens indicated that kinetic analysis by the plasma slope method would be appropriate for the study of their turnover. Because terminal hydrolysis products ofradioiodinated proteins are excreted at finite rates, methods of protein turnover analysis which involve measurement of urine radioactivity (24) can be inaccurate in the case of rapidly metabolized proteins (23 Our results indicated that turnover of plasma kininogens conformed to double exponential equations. In measuring turnover by the plasma slope method, we assumed a simple system consisting of two pools: the intravascular pool into which radiolabeled kininogen was injected, and the single extravascular pool into which the injected kininogen diffused, or was catabolized. As we did not attempt complicated multicompartmental modeling analysis during our present study, the pools did not represent specific anatomic compartments, but were pools only in a kinetic sense. According to our assumption, kininogen could exit from the intravascular pool by only two processes: diffusion or catabolism. If our double exponential hypothesis were correct, the sum of the constants for the fraction of injected protein that diffuses (Cl) and the fraction that is catabolized (C2) should approximate 100%. As our data indicated, the average values for C1 + C2 were close to the predicted value, which suggests that there were no overlooked components to the equation describing kininogen turnover in plasma. We confirmed this observation by testing the fit of our data to triple exponentials, and observed no notable improvement in correlation coefficient. These results are in contradistinction to those observed in studies of fibrinogen turnover which, although said to conform to double exponential equations, indicate the presence of a small (2-3%) third component in their turnover curves (23) .
Analysis of our kininogen turnover curves was simplified, and accuracy was improved considerably with the SAAM computer program. Without the program, the constants for the double exponential equations would have had to be estimated by graphic means. By extrapolation of the terminal portion of the turnover curves to time 0, the y-intercept (C2) and slope (-b) of the second exponential could be obtained, and by subtraction of the second exponential from the total curve, the constants (Cl and -a) for the first exponential could be calculated. With the SAAM program, we were able to perform iterations of the data to obtain constants for the curve that provided the best fit of our data to more than two exponentials without difficulty.
To follow the disappearance of radiolabeled kininogen from the intravascular pool, we compared measurements of whole blood, plasma, and antibody-precipi- O I1 TIME (HOUR) tated kininogen radioactivities. There were no differences in turnover curves obtained with any of the three methods of analysis, although the last method was clearly the most specific. We were not able to measure the radioactivity of functionally active kininogen as opposed to kininogen antigen. In studies of fibrinogen turnover, this problem is not encountered because plasma samples can be clotted and the radioactivity of the fibrin contained within the clots counted. However, fibrinogen turnover curves obtained by measuring plasma radioactivity were nearly identical to those obtained by measuring radioactivity of clottable protein (25) . While we cannot exclude the possibility that kininogen may continue to circulate in the intravascular pool as measurable antigen even after partial catabolism, it is unlikely, as a common pathway for diffusion and catabolism is suggested by the observation that the catabolic pattern for kininogen was superimposed by a similar kinetic for its diffusion.
The differences we observed between the kinetics of HMW and LMW kininogens cannot be explained simply on the basis of molecular size, because albumin, with a molecular weight less than that of LMW kininogen, has a tl12 nearly four times as long (20) . The differences in Fc of the two kininogens were attributable primarily to differences in their ev/iv. It is tempting to speculate about the functions of the two kininogens in relation to their pool distribution, but we have little data with which to support such conjectures. However, the importance of HMW kininogen in the coagulation process has been well documented (26) (27) (28) (29) , although the specific in vivo functions of the various kininogens are otherwise unknown. In addition, Pierce and Guimaraes (10) as well as Habal et al. (30) have corroborated earlier observations by Jacobsen and Kriz (31) that HMW kininogen is the preferred substrate for plasma kallikrein. These two observations are consistent with the predominant intravascular distribution of HMW kininogen, but do not shed further light on the relationship between distribution and function of the kininogens.
Turnover of rhesus monkey kininogens was similar to that of human kininogens when measured in monkeys. This was to be expected in view of the similarities between the kininogens of the two species. However, Regoeczi has shown that in rabbits, human fibrinogen disappeared at 1.45 times the rate of homologous fibrinogen before immunologic clearance mechanisms were activated (32) . Similar studies in monkeys that were injected with human fibrinogen showed its clearance rate to be 1.3 times faster than that of the homologous fibrinogen, despite the absence of any detectable immune response (23) . The difference in clearance rates was attributable to differences in diffusion rates as well as in ev/iv. We did not observe any significant differences in plasma tl/2 between monkey and human kininogens, but the former had a slower catabolic rate than its human counterpart, and this difference was apparently related to the former's significantly greater distribution into the intravascular pool. The differences in ev/iv between the heterologous and homologous LMW kininogens may reflect differences in their functional characteristics in monkeys.
In their description of a patient with Flaujeac factor deficiency (16), a disease later shown by Wuepper et al. to be caused by deficiency in HMW kininogen (27) , Lacombe et al. reported that the functional abnormality in coagulation observed in their patient could be corrected in vivo by the infusion of fresh frozen plasma. The factor(s) in fresh frozen plasma which corrected the functional deficiency had a t1/2 of 6.5 days. Although this observation is apparently at variance with our t1/2 for HMW kininogen of 25.95 h, several important differences between Lacombe's study and ours must be considered: (a) their study reports in vivo functional t1/2, whereas our t1/2 was derived from plasma disappearance curves; (b) the exact substance of which t1/2 was inferred in Lacombe's study is unclear, because they used fresh frozen plasma for infusion rather than purified HMW kininogen; (c) their t1/2 curve was drawn from three points in a single patient after one infusion of fresh frozen plasma; and (d) a species difference in metabolic turnover of HMW kininogen cannot be excluded.
Because of their unique and potent physiologic actions, the kinins have been implicated in the pathophysiology of a number of severe clinical illnesses. Evidence of kinin system activation in these illnesses, however, has been inferential for the most part, because turnover of the proteins involved has not been evaluated. We have studied the syndrome of disseminated intravascular coagulation in Salmonella typhimurium-infected rhesus monkeys and, as in other illnesses with suspected kinin system participation, our evidence of kinin activation has been limited to the indirect observations of elevated kallikrein and diminished prekallikrein and kininogen (33) . We are presently attempting to clarify the association between kinins and clinical illness by direct study of kininogen turnover in our infected monkeys, and by comparing with the normal studies presently discussed. In this fashion, we hope to be able to document the involvement of the kinin system in disseminated intravascular coagulation and to evaluate various potential therapeutic measures in relation to their effect on the kinin system. The technique for measuring kininogen turnover should also be applicable to the study of other illnesses in which the kinin system is thought to play an important pathophysiologic role.
